Knowledge Hub

The Americas Pharmaceutical & Healthcare Reports - Market valuations and 5-year forecasts

Press Release   •   Nov 29, 2016 04:41 EST

The Americas Pharmaceuticals & Healthcare Reports feature independent forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

Why These Reports are Important

Despite on-going economic pressures, the pharmaceutical industry is one of the most successful in terms of its operation. Many leading pharmaceutical companies dominate key markets through product innovation, successful marketing, effective products and strategic alliances. In addition, the sector supports thousands of drug discovery and development companies.

With an emphasis on globalisation, you could be forgiven for thinking that national markets are becoming less important. However, it is the national marketplace in which companies have to work. Domestic priorities set the agenda that affects a company's operations. It is the prevailing political outlook, economic performance, health economy, social and demographic trends and cultural views that need to be understood and planned for to ensure optimum return on investment.

These Insightful Reports Bring Real Business Benefits:

Market valuations and 5-year forecasts for each market

A review of market regulation, product approval, market access and intellectual property

An assessment of domestic production and trade

A comprehensive, complete and critical evaluation with SWOT assessment

Focus on OTC and generic, and the increasingly important biologic/biosimilar sectors

Detailed statistics on demography, health funding, health provision, personnel and facilities

Download Sample Copy of Report at

The Americas Pharmaceuticals & Healthcare Reports cover






Puerto Rico

Central America





All 11 Countries

With The Americas Pharmaceuticals and Healthcare Reports you can easily evaluate these markets. Each report provides individual and highly-detailed analysis of the market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually or as a discounted collection.